|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A01N 43/04 | |
| C07H 15/04 |
| (11) | Patento numeris | 2900061 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13837458.2 |
| Europos patento paraiškos padavimo data | 2013-09-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-08-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-01-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/060182 |
| Data | 2013-09-17 |
| (87) | Numeris | WO 2014/043708 |
| Data | 2014-03-20 |
| (30) | Numeris | Data | Šalis |
| 201261701914 P | 2012-09-17 | US | |
| 201361756818 P | 2013-01-25 | US | |
| 201361759532 P | 2013-02-01 | US |
| (72) |
TRABER, Peter, G., US
REDMOND, William,L., US
ZOMER, Eliezer, US
KLYOSOV, Anatole, US
LINCH, Stefanie, N., US
|
| (73) |
Galectin Therapeutics Inc.,
4960 Peachtree Industrial Blvd. Suite 240, Norcross, GA 30071,
US
Providence Health & Services Oregon d/b/a Earle A. Chiles Research Institute of the Robert W. Franz Cancer Res. Cent., 4805 NE Gilsan Street, 2N35, Portland, OR 97213, US |
| (54) | METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT |
| METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT |